Table S1. Characteristics of pediatric patients with COVID-19.

(1)

Table S1. Characteristics of pediatric patients with COVID-19.

Variables Patient no. 1 Patient no. 2 Patient no. 3 Patient no. 4

Age - yrs 1 3 4 5

Sex Female Male Male Male

Symptoms

Fever Yes No Yes Yes

Myalgia No No No No

Cough No Yes Yes

Fatigue No Yes No Yes

Dyspnea No Yes No No

Anorexia No Yes No No

Headache No No No No

Expectoration-sputum production No No No No

Nausea/vomiting No No No Yes

Diarrhea No No No

Dizziness No No No Yes

Sore throat No No No No

Abdominal pain No No Yes Yes

Rhinorrhea No No No No

Hemoptysis No No No No

Duration between symptoms and hospitalization - days 4 7 6 1

Duration between symptoms & dyspnea -days N/A 7 N/A N/A

Oxygen saturation below 90% Yes No Yes Yes

Hospital stay-days 14 6 ^a 5

Vital signs

Fever more than 38 Yes No No Yes

Tachypnea No Yes ^a No

Tachycardia No No ^a No

Hypertension No No ^a Yes

White blood cell count ^a 12 800 ^a 47 200

Hemoglobin - g/dl 9.2 13.8 ^a 11.4

Platelet count - per microliter 62 000 187 000 ^a 297 000

C-reactive protein - mg/l 75 102 ^a 150

Erythrocyte sedimentation rate - mm/hr 43 56 ^a 14

Prothrombin time - seconds ^a 16 ^a 12.5

International normalized ratio ^a 1.7 ^a 1.04

Partial thromboplastin time - seconds ^a 28 ^a 25

Albumin - g/dl 3.7 2.7 ^a 4.7

Aspartate aminotransferase - IU/L ^a 50 ^a 500

Alanine transaminase - IU/L ^a 28 ^a 140

Alkaline phosphatase - IU/L ^a 162 ^a 175

Sodium - mEq/l ^a 141 139 136

Potassium - mEq/l ^a 4.5 4 5

Blood urea nitrogen - mg/dl ^a 22.3 20 17

Creatinine - mg/dl ^a 0.6 1.7 0.9

Lactate dehydrogenase ^a 1277 500 1211

Blood group O+ O+ B- O+

(2)

PELD score 26 ^a 17 14

Cause of liver failure Tyrosinemia Biliary atresia PFIC PFIC

Type of graft Living Living Living Whole organ

Duration between transplantation and COVID-19 - months 10.5 18 0.4 38.0

PFIC: Progressive familial intrahepatic cholestasis; PELD: pediatric end-stage liver disease

aData on this were missing.